Vaccine-induced escape mutant of hepatitis B virus. 1990

W F Carman, and A R Zanetti, and P Karayiannis, and J Waters, and G Manzillo, and E Tanzi, and A J Zuckerman, and H C Thomas
Department of Medicine, St Mary's Hospital Medical School, London, UK.

In southern Italy, 44 contacts of hepatitis B virus carriers, including infants of carrier mothers, became HBsAg positive despite passive and active immunisation according to standard protocols. In 32 of these vaccinees infection was confirmed by the presence of additional markers of viral replication. In 1 infant, serious disease occurred. The virus from this patient is an escape mutant with a different sequence from that of the isolate from the mother. A point mutation from guanosine to adenosine at nucleotide position 587 resulted in an aminoacid substitution from glycine to arginine in the highly antigenic a determinant of HBsAg. This mutation is stable: it is present in an isolate from the child 5 years later. In some of these patients, including this child, the a determinant, to which a large part of the vaccine-induced immunity is directed, has been partly lost. Binding to HBsAg of a monoclonal antibody, previously mapped to the region of the mutation, was reduced in the child relative to that of the mother.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007558 Italy A country in southern Europe, a peninsula extending into the central Mediterranean Sea, northeast of Tunisia. The capital is Rome. Sardinia
D008297 Male Males
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D002353 Carrier State The condition of harboring an infective organism without manifesting symptoms of infection. The organism must be readily transmissible to another susceptible host. Asymptomatic Carrier State,Asymptomatic Infection Carrier,Inapparent Infection Carrier,Presymptomatic Carrier State,Presymptomatic Infection Carrier,Super-spreader Carrier,Superspreader Carrier,Asymptomatic Carrier States,Asymptomatic Infection Carriers,Carrier State, Asymptomatic,Carrier State, Presymptomatic,Carrier States,Carrier, Super-spreader,Carrier, Superspreader,Carriers, Super-spreader,Carriers, Superspreader,Inapparent Infection Carriers,Infection Carrier, Asymptomatic,Infection Carrier, Inapparent,Infection Carrier, Presymptomatic,Presymptomatic Carrier States,Presymptomatic Infection Carriers,Super spreader Carrier,Super-spreader Carriers,Superspreader Carriers
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006514 Hepatitis B Surface Antigens Those hepatitis B antigens found on the surface of the Dane particle and on the 20 nm spherical and tubular particles. Several subspecificities of the surface antigen are known. These were formerly called the Australia antigen. Australia Antigen,HBsAg,Hepatitis B Surface Antigen,Antigen, Australia

Related Publications

W F Carman, and A R Zanetti, and P Karayiannis, and J Waters, and G Manzillo, and E Tanzi, and A J Zuckerman, and H C Thomas
January 1991, Journal of hepatology,
W F Carman, and A R Zanetti, and P Karayiannis, and J Waters, and G Manzillo, and E Tanzi, and A J Zuckerman, and H C Thomas
January 2015, Human vaccines & immunotherapeutics,
W F Carman, and A R Zanetti, and P Karayiannis, and J Waters, and G Manzillo, and E Tanzi, and A J Zuckerman, and H C Thomas
January 2003, Journal of gastroenterology,
W F Carman, and A R Zanetti, and P Karayiannis, and J Waters, and G Manzillo, and E Tanzi, and A J Zuckerman, and H C Thomas
December 2005, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology,
W F Carman, and A R Zanetti, and P Karayiannis, and J Waters, and G Manzillo, and E Tanzi, and A J Zuckerman, and H C Thomas
January 2001, Journal of biomedical science,
W F Carman, and A R Zanetti, and P Karayiannis, and J Waters, and G Manzillo, and E Tanzi, and A J Zuckerman, and H C Thomas
January 2018, Frontiers in medicine,
W F Carman, and A R Zanetti, and P Karayiannis, and J Waters, and G Manzillo, and E Tanzi, and A J Zuckerman, and H C Thomas
June 2001, Journal of Korean medical science,
W F Carman, and A R Zanetti, and P Karayiannis, and J Waters, and G Manzillo, and E Tanzi, and A J Zuckerman, and H C Thomas
September 2013, Hepatology (Baltimore, Md.),
W F Carman, and A R Zanetti, and P Karayiannis, and J Waters, and G Manzillo, and E Tanzi, and A J Zuckerman, and H C Thomas
September 2022, Nature communications,
W F Carman, and A R Zanetti, and P Karayiannis, and J Waters, and G Manzillo, and E Tanzi, and A J Zuckerman, and H C Thomas
December 1992, The Journal of clinical investigation,
Copied contents to your clipboard!